Glooko Insights
Stay up-to-date on our latest news and insights, enhancements to our connected care platform, and Team Glooko happenings.
How Glooko Advances Diabetes Care and Management in the NHS 10 Year Health Plan
August 25, 2025Glooko aligns with the NHS's 10 Year Health Plan by driving digital transformation, enabling remote care, and fostering prevention for better diabetes outcomes.
Learn moreComplexity to Clarity: How Glooko’s Device Integrations Simplify Diabetes Care
August 7, 2025Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care. At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes. The Challenges of Fragmented Diabetes Management For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face: Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health. Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health. Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change. These challenges contribute to missed opportunities for timely interventions that drive better health outcomes. How Glooko’s Compatibility Brings Clarity to Diabetes Care Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform. Here’s how Glooko’s device compatibility transforms care: Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform. Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits. Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html. The Many Benefits of Integration for Clinics, Hospitals, and Health Systems Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need. Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients. Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans. Expanded Clinical Footprint: With more time, clinicians can help more patients in need. To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden. The Key Benefits of Device Integrations for People Living with Diabetes Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions. Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider. Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health. Proven Results Backed by Global Expertise Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard. Simplify Diabetes Care with Glooko The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes. Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.
Learn moreOptimizing Diabetes Management with Glooko and Hybrid Closed Loop Systems
July 30, 2025As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps. With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other. Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock. How Glooko integrates with hybrid closed loop systems Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes. The hybrid closed loop systems that currently sync with Glooko include: mylife Loop (CamAPS FX and Ypsomed) Tandem Control-IQ Insulet Omnipod 5 Dana CamAPS® FX Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems. Method 1 Method 2 Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries). Benefits of using hybrid closed loop systems with Glooko There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including: Major changes in treatment that reduce daily burdens and mental stress More time with glucose levels in range with less effort The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including: An increased monitoring of patients with diabetes who are using closed loop systems Strengthening their connection with their patients Better management of fluctuations in patients’ glucose levels Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses The future of hybrid closed loop systems Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life. As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution. For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.
Learn more2025 Global Diabetes Report: Transforming Diabetes Management Through Actionable Insights
June 20, 2025The Glooko 2025 Global Diabetes Report offers a comprehensive look at how real-world data can drive better outcomes in diabetes care. Powered by billions of data points across 30+ countries, this report uncovers meaningful trends in glycemic management, technology adoption, and behaviors among people living with Type 1, Type 2, and gestational diabetes. From the rise of remote monitoring to the impact of advanced technologies like Continuous Glucose Monitors (CGMs) and Automated Insulin Delivery (AID) systems, this report explores how personalized insights can be used to better inform personalized care, predict risk, and guide clinical decision-making. Whether you’re a clinician, researcher, or innovator in diabetes management technology, this report highlights how data can be turned into action — helping to shape a smarter, more connected future of diabetes management. Download the report
Learn moreTransforming Diabetes Management: A Step Forward with Abbott’s FreeStyle Libre CGMs and Glooko
June 18, 2025At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing. As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solution for diabetes management. This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information. From glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health. As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.
Learn moreTransforming Diabetes Care in the United Kingdom: Shaping the Future through Technology, Data, and Partnerships
June 9, 2025In the United Kingdom, diabetes technology has rapidly advanced over the past two decades, with platforms like Glooko playing a central role in simplifying care and management. In honor of Diabetes Week U.K. (9 June to 15), we’re taking a look at the state of diabetes, technology designed to better manage the condition, and the outlook on the evolution of diabetes care and technology. The State of Diabetes in the United Kingdom Diabetes is a significant public health concern in the U.K. According to Diabetes U.K., more than 5.8 million people are currently living with the condition. Of these, approximately 4.6 million have been diagnosed and an estimated 1.3 million people may be living with undiagnosed Type 2 diabetes. Of those diagnosed with diabetes in the U.K., Type 2 diabetes accounts for approximately 90% of cases. While risk factors for Type 1 diabetes include family history and the presence of other autoimmune conditions, Type 2 diabetes risk is heightened obesity, family history, a history of gestational diabetes, specific medications, and other factors. To address the growing prevalence of diabetes and support those affected, the National Health Service (NHS) offers various education programs aimed at empowering individuals with the knowledge and skills necessary to manage their diabetes effectively, improve health outcomes, and reduce the risk of complications. For individuals with Type 2 diabetes, programs like DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) and the X-PERT Diabetes Programme provide education on managing the condition through lifestyle changes and self-monitoring. For those with Type 1 diabetes, the DAFNE (Dose Adjustment For Normal Eating) program offers guidance on insulin management and dietary considerations and Digibete helps young people, families, and communities better manage Type 1 diabetes. Additionally, the VICTOR program is designed for adults with Type 2 diabetes who are on insulin therapy and focuses on adjusting insulin doses in response to routine changes. Diabetes Technology Today In the U.K., diabetes technology is advancing quickly with Glooko helping streamline data management across compatible diabetes and health monitoring devices, including: Hybrid closed loop (HCL) systems, which combine continuous glucose monitoring (CGM) with insulin pumps to automatically adjust insulin delivery based on real-time data. Devices like Tandem t:slim X2 require cable downloads, while mylife Loop powered by CamAPS® FX and Omnipod® 5 use cloud-to-cloud integration. CGMs provide glucose trends and alerts and are often compatible with pumps and cloud platforms. Abbott FreeStyle Libre CGMs data can be seen within Glooko through the upload of data from HCL-compatible insulin pumps. Fitness and health monitoring apps can track steps, weight, and blood pressure. Smart pens and connected pens allow for remote or in-clinic dose tracking. Transforming Diabetes Care in the United Kingdom with Glooko Across the country, more than 85,000 people living with diabetes use Glooko’s digital health platform to manage their diabetes and more than 500 clinics are using Glooko to provide better care to their patients.* Through our data*, we identified key metrics for time in range for people with Type 1, Type 2, and gestational diabetes in the U.K. using Glooko during 2024. Type Time In Range (TIR) | 3.9-10 mmol/l Time in Tight Range (TITR) | 3.9-7.8 mmol/l Type 1 Diabetes 64% 41% Type 2 Diabetes 58% 34% Gestational Diabetes 74% 50% Today, there is an increased interest in TITR and TIR as a result of the recent technology available for managing diabetes. The Glooko diabetes data management platform helps healthcare providers monitor TIR and TITR to improve glycemic outcomes for people living with diabetes, bringing data from multiple devices into one platform with comprehensive charts and graphs. It ensures consistent data access — even without connected devices — and meets high standards for data protection, including GDPR compliance, to support safe, effective, and standardised diabetes care. The Future of Diabetes Care in the United Kingdom The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes. Progress also depends on strong partnerships with leading diabetes organisations like the Diabetes Technology Network (DTN-UK) and Diabetes National Networking Forums (NNF). The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes. By showcasing technologies such as hybrid closed loop systems at local events from these leading organisations and through initiatives like our Academy program, a collaboration between Glooko and the Association of British Clinical Diabetologists(ABCD)/DTN-UK providing free education for medical professionals in the U.K., we help educate, support, and empower both clinicians and people living with diabetes across the country. *Internal Glooko data; based on active Glooko users that synced during 2024
Learn moreNew Glooko Web 25.1 and Mobile 6.11 Release Enhances Reporting and Security
June 5, 2025As part of our ongoing commitment to supporting healthcare providers and people living with diabetes, we’re excited to share the latest enhancements and features now available in Glooko Web 25.1 and Mobile 6.11. These updates are designed to streamline workflows, improve patient engagement and security, and provide care teams with more robust tools to manage diabetes care effectively. Patient Notes and Medications in Week View Care teams and people living with diabetes can now view notes and medication entries added to the Glooko Mobile and Web App directly in Week View, both online and in PDF reports. These entries appear in a new collapsible “Events” section below each day, making it easier to contextualize trends in glucose data and treatment behaviors. Streamlined Week View PDF Reports In our new release, Week View PDFs are now cleaner and more efficient. Sections without data will be automatically hidden, allowing more patient data over a few days to fit on each page. The glucose and statistics sections will always remain, and a single, comprehensive legend will now appear at the end of the report. Smarter Defaults in the PDF Wizard for Hybrid Closed Loop Systems Designed to streamline reporting workflows and help care teams quickly access the most meaningful insights, the Glooko PDF Wizard now automatically pre-selects the most relevant reports, including Summary, Week, Daily, and Devices, when a patient uses a Hybrid Closed Loop System like Omnipod® 5, Tandem t:slim X2 with Control-IQ technology, or mylife Loop powered by CamAPS® FX. Care teams can still customize the selections as needed. Enhanced Security in the Glooko Mobile App At Glooko, we’re committed to the security and safety of our platform users. People living with diabetes, including those under age 18, can now manage their login credentials (email and password) through a new Login Security section in the Glooko Mobile App’s Account Settings. We’ve also expanded support for two-factor authentication (2FA) to users to ensure an extra layer of protection. Explore More Updates For more detailed information about the new features designed to simplify diabetes management, be sure to check out the full release notes on the Glooko Support Center.
Learn moreFrom Clinic to Innovation: Guiding Glooko’s Future in Diabetes Management
June 3, 2025As healthcare providers, we find ourselves at a pivotal moment in diabetes management. Technological advances — from remote patient monitoring to artificial intelligence — have dramatically reshaped patient care. Yet, amid these innovations, a crucial element often remains overlooked: the voices of clinicians and people with diabetes. In my new expanded role as Chief Medical and Strategy Officer at Glooko, I am excited about the opportunity to transition from direct patient care into a broader role where I can continue to make a significant impact on diabetes management and improve the lives of people with diabetes. I believe my firsthand clinical experience positions me uniquely to guide Glooko’s innovation efforts, ensuring we build tools that genuinely meet the needs of clinicians and people with diabetes alike. In my nearly two decades as a pediatric endocrinologist, I’ve observed the profound potential—and the challenges—of integrating digital solutions into daily diabetes management. Clinicians routinely manage a complex array of tasks: reviewing glucose data from continuous glucose monitors (CGMs) or meters, adjusting insulin regimens, coaching patients on lifestyle, documenting clinical decisions, and coordinating across care teams. With a single person’s CGM device generating up to 288 data points per day, 1 clinicians managing numerous people with diabetes face overwhelming workloads. Individuals with diabetes echo similar concerns. Many describe data fatigue from constant management and analysis of their glucose levels. As one person stated, “The data is overwhelming; without clear insights and simpler ways to interpret it, it’s just noise.” Although this wealth of data is invaluable, it contributes significantly to clinician burnout, and burn out among people with diabetes. Alarmingly, half to two-thirds of clinicians experience burnout, driven largely by bureaucratic tasks, extended working hours, and the sheer volume of data management.2,3 Individuals with diabetes also report significant stress from managing their condition daily. Every glucose reading can feel like a pass or fail test. Effective technological integration could alleviate such emotional burdens by making data actionable, intuitive, and less intrusive. At Glooko, we recognize that technology alone is not sufficient—it must seamlessly integrate into clinician workflows. Clinicians offer essential insights into behaviors of individuals, adherence barriers, and preferences. Unfortunately, many digital diabetes solutions miss the mark due to inadequate clinician input, leading to underutilization—only about 40% see active clinical use.4 Glooko addresses this by ensuring clinician insights directly shape our technology, streamlining workflow integration through interoperability with electronic health records (EHRs). In a similar vein, simplicity and intuitive user experiences are paramount for people with diabetes to properly leverage diabetes management technologies. If the technology is complicated, it just becomes another barrier. Today, our connected care platform exemplifies this integrated approach, merging patient-generated data with clinical decision-making tools. Evidence demonstrates connected care significantly improves diabetes outcomes, with reductions in HbA1c levels of up to 1.5% and fewer hypoglycemic events.5 Glooko enables clinicians to swiftly identify high-risk trends and proactively manage care for people with diabetes. Tomorrow, AI-driven predictive analytics within Glooko could transform diabetes management by forecasting hypoglycemic and hyperglycemic events, facilitating timely, preventive interventions. Automating routine data analysis tasks can reduce clinicians’ documentation burdens by approximately 30%,6,7 significantly alleviating stress and freeing clinicians to focus more deeply on clinical interactions. For people with diabetes, this can provide a significant improvement in their overall diabetes management. I believe Glooko has immense potential, especially through advanced analytics and decision support. For instance, we could empower clinicians to shift from generalized treatment plans to highly personalized management strategies, grounded in timely data. Innovation that is guided by those on the frontlines of care — people with diabetes and their care providers — is critical for meaningful advancements that can truly move the needle in diabetes care. In my role, I am dedicated to ensuring our solutions enhance workflows, support better outcomes, and ultimately bring a human-centric approach to diabetes management. Together, we will define the future of diabetes care, directly addressing challenges clinicians face and improving the lives of those we treat. Here’s to a bright future ahead! 1. Speakman, ASHP. 2. Hammes et al., Endocrine News; Medscape Endocrinologist Lifestyle Report, 2022. 3. Batta et al., BMJ Open Diabetes Res Care. 4. Shah et al., J. Diabetes Sci Technol., 2023.5. Su et al., J. Med Internet Res., 2023. 6. AMA Digital Health Report. 7. Sidharthan et al., Scientific Reports, 2025.
Learn moreThe Power of Food Logging: A Smarter Way to Manage Diabetes with Glooko
May 15, 2025Food and nutrition play a vital role in achieving a healthy lifestyle. This is particularly important in diabetes management, especially for people living with Type 2 diabetes. In the Glooko Mobile App available on the App Store and Google Play Store, people living with diabetes can easily log what they eat at home or while on the go using our food tracking feature, a popular functionality that always receives praise from our users. Through our integration with the world’s largest dietitian-verified grocery database of more than 1 million items from over 46,000 grocery brands, users of the Glooko Mobile App can accurately track their meals and snacks in a variety of ways and create a personal log to better understand how food and nutrition impacts their diabetes. Glooko offers many options for logging food intake: Search the largest grocery database on the planet: Easily find and add generic or branded foods by typing the name into the app. Learn how to use this feature… Use the innovative voice capture capability: Simply speak the name of a food item to log it in Glooko. Find out how to use the voice capture feature… Scan barcodes: Use a smartphone camera to scan packaged food barcodes to instantly access nutritional information and effortlessly add to the app’s log. See how to use the barcode scanner functionality… By viewing food and nutrition data, including carbohydrates, calories, fats, and proteins, alongside insights from their connected diabetes and health monitoring devices, medications, and insulin, users can uncover trends and make smarter food choices. Since people don’t need to log into multiple platforms to manage both their diabetes and nutrition data, we’ve recently seen an increase in food logging frequency and more tracking of localized food items around the world. More ways to eat smart and track more effectively using the Glooko Mobile App To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions. Frequent users can also save time by creating custom food entries for their favorite meals — perfect for quick re-logging of their go-to foods. To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions. Glooko Mobile App users can complement their food logging with quick notes using free text or the dropdown menu option to provide details like miscalculated carbs, overeating, dining out, or skipped meals. These notes help communicate important context to their healthcare team who can provide more information dietary or medication recommendations as needed. Share nutrition data with healthcare providers While we’ve really focused on the benefits of food tracking for people living with diabetes, healthcare providers and care teams also benefit from this feature. They can view this logged nutrition data alongside their patients’ other health data in Glooko to have a more comprehensive view of everything affecting their patients’ diabetes. The evolution of our food tracker Glooko plans on further innovating its app to provide advanced food analysis tools, including micronutrients, more photos, and easier logging, and personalized nutrition insights with real-time feedback on how specific food choices directly impact a person’s health. An advanced, data-driven approach will empower people living with diabetes to make even timely, smarter, and more informed decisions about their health. Download the Glooko Mobile App today Ready to take diabetes management to the next level? Download the Glooko Mobile App from the App Store or Google Play Store and start logging food, tracking health data, and uncovering insights that support better living with diabetes.* *Not all product features are available in all countries. *Not all product features are available in all countries.
Learn moreDesign a New Resistance Exercise Program With Glooko’s Resident Fitness Expert!
October 30, 2023Glooko's Sanaz Nosrat, PhD, CSCS, ACE PT outlines the benefits of resistance exercise and will give people with diabetes some tips on how to design and stick to a program.
Learn moreTips for Better Diabetes Management When Travelling
August 17, 2023Glooko’s Amanda Stoney, RN (CHILD), BSc (HONS), Specialist Practitioner, PG Certificate shares tips for better diabetes management when travelling.
Learn moreDesign A New Aerobic Exercise Program with Glooko’s Resident Fitness Expert
June 14, 2023Glooko's Sanaz Nosrat, PhD, CSCS, ACE PT outlines the benefits of aerobic exercise and how to design a workout program for people living with diabetes.
Learn moreGlooko Launches Sleek New Mobile App Design to Make Diabetes Management Easier
May 9, 2023The Glooko® Mobile App has a new design to make it easier for users with diabetes to navigate, organize data in one place and share data with their care teams.
Learn moreTime to Move More! The Benefits of Exercise and Physical Activity from Glooko’s Resident Fitness Expert
April 10, 2023In a new blog series, Glooko's Sanaz Nosrat, PhD, CSCS, ACE PT shares the benefits of physical activity for people with diabetes and ways to increase daily exercise.
Learn moreInsulet’s Omnipod 5 Compatible with Glooko
March 1, 2023Glooko's diabetes and chronic conditions management platform is compatible in the U.S. with Insulet Corporation’s Omnipod® 5 Automated Insulin Delivery System.
Learn moreGlooko Mobile App Simplifies Tracking Food Intake for People with Diabetes
January 18, 2023People with diabetes can use the Glooko mobile app to easily log their food intake and keep a historical account of how food affects their chronic condition.
Learn moreConquer the Holidays While Living with Diabetes with Tips from Glooko’s Registered Dietitian
December 21, 2022Glooko's Bridget Wood, RD, LD, CDCES shares helpful healthy eating tips for people with diabetes during the holidays and a blood sugar friendly recipe.
Learn moreTackling Blood Sugar Challenging Foods with Glooko’s Registered Dietitian During Diabetes Month
November 29, 2022In honor of Diabetes Awareness Month, Glooko's Bridget Wood, RD, LD, CDCES tackles blood sugar challenging foods for people with diabetes and shares a delicious recipe.
Learn moreMission-Driven Head of Support Helps Enhance Glooko Platform and App
November 28, 2022Phil Krieg, Glooko's global head of customer support and supply chain who has type 1 diabetes, collects customer feedback to enhance the digital health platform.
Learn moreGlooko: A Career Path and Tool for Managing his Daughter’s Diabetes
November 18, 2022Patrick, a senior account manager at Glooko, helps his young daughter, Nuala, manage her type 1 diabetes using our digital health app while enhancing its functionality.
Learn moreCollaboration and Advocacy Define Hadley’s Experience Living with Type 1 Diabetes
November 10, 2022In honor of American Diabetes Month, we’re sharing stories of Team Glooko members who are living with diabetes or helping a family member who is impacted by the chronic condition. Hadley Horton, a partner manager at Glooko, was diagnosed with type 1 diabetes in November of 2009. When she’s not staying active to keep her blood sugar stabilized, she acts as an advocate for people with diabetes. She believes those with diabetes understand and are aware what it means to live with the condition best. In the past, she’s mentored youth with diabetes and their peers to remind them they’ll lead a normal life just like she has. Based in Denver, Colorado, her role at our connected care company allows her to collaborate with teams across Glooko and our partner, Insulet, on how to expand and improve our digital health platform. “In order to have a successful partnership, you need to work with everyone from product developers to patients,” said Hadley. “My role has given me a new perspective into the digital therapeutics space, as well as understanding of the broader diabetes industry.” With her knowledge from working alongside partner companies, living with diabetes and using the Omnipod 5 in her daily life, she’s able to lend valuable insights into the continuous development of the Glooko app to enhance our product for users around the world. Listen to her story. MKT-0407 01
Learn moreHealth Benefits of a Plant-Based Diet for People Living with Diabetes from Glooko’s Registered Dietitian for Vegetarian Awareness Month
October 25, 2022For Vegetarian Awareness Month, Glooko's Bridget Wood, RD, LD, CDCES shares the health benefits of diets rich with plant-based foods for people with diabetes.
Learn moreCelebrate Food Literacy Month with Healthy Meal Planning Tips from Glooko’s Registered Dietitian
September 28, 2022For Food Literacy Month, Glooko's Bridget Wood, RD, LD, CDCES shares what to look for on Nutrition Facts Labels when planning healthy balanced meals.
Learn moreNutritious Back-to-School Recipes and Meal Prep Tips from Glooko’s Registered Dietitian
August 30, 2022With children heading back to school, Glooko's Bridget Wood, RD, LD, CDCES shares tips and easy-to-make recipes for nutritious and diabetes-friendly meals.
Learn moreGet Grilling This Summer with Healthy Tips from Glooko’s Registered Dietitian Nutritionist
July 29, 2022In honor of National Grilling Month, Glooko's Bridget Wood, RD, LD, CDCES shares healthy grilling tips for people with diabetes and an easy-to-make recipe.
Learn moreHealthy Summer Eating Tips from Glooko’s Resident Registered Dietitian Nutritionist
June 21, 2022Glooko's Bridget Wood, RD, LD, CDCES shares healthy summer eating tips designed for people with diabetes along with an easy-to-make recipe.
Learn moreNew Food Database Languages and Regional Items in the Glooko App Enable Users to Better Track Food Intake
April 4, 2022In Glooko Mobile Release Version 5.18, we updated our food database in our mobile app to better support users in the U.K., France, Germany and Spain. The app’s database, which has more than 500,000 items, now has new, unique regional food items that are searchable in British English, French, German and Spanish and offers users the ability to explore nutritional facts, including carbohydrates, calories, fats and proteins.
Learn moreNational Blood Donor Month
January 17, 2019January is National Blood Donor Month and while not everyone with diabetes may be eligible to donate their blood, it got us thinking of just how MUCH blood people with diabetes give to their diabetes care.
Learn moreSondra Uses Glooko to Share Her Diabetes Data with Her Care Team
November 15, 2017Using the Glooko mobile app, Sondra, a person living with type 2 diabetes, remotely shares her diabetes data with her doctor and care team, which makes her appointments more productive.
Learn moreSteven Shares How He Tracks His Carb Intake with Glooko
September 5, 2017Steven, who uses the Omnipod® System and Dexcom® CGM, leverages the Glooko mobile app's food database to easily count his carbs and better manage his diabetes.
Learn moreNutrition Recommendations from a Registered Dietitian
July 18, 2017Nutrition is extremely important for everyone, especially if you have diabetes. Some of us look at the nutrition facts on food labels and count calories,
Learn moreIndividual Differences in Fasting Blood Glucose (FBG)
June 21, 2017A fasting blood glucose (FBG) reading between 70-100 mg/dL is typically regarded as normal in people without diabetes 1. While this range serves as a standard
Learn moreImpacting Diabetes in Asia, One Person At A Time
February 10, 2016She is a mom of two kids ages 12 and 8 and a loving wife. She is an HR Specialist who works 4 days a week, a special arrangement with a supportive boss.
Learn more